As a result of recently completed initial testing in vitro on loaded Nuvec® with two generic siRNA probes, N4 Pharma has created an infographic outlining the key results and detailing how Nuvec® works to deliver multiple siRNA into the same cell.
With siRNA increasingly being used in the development of therapeutics, particularly in Oncology, the ability of Nuvec® to deliver multiple payloads makes it a unique delivery platform for developing novel combination therapies for cancer and vaccine treatments.
In N4 Pharma’s new infographic, you can learn more about how Nuvec® works and what its benefits are here.
